16:47 EST BioXcel Therapeutics (BTAI) files to sell 5.1M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTAI:
- Bioxcel Therapeutics Revises Executive Compensation Structure
- BioXcel Therapeutics downgraded to Underperform from Buy at BofA
- BioXcel Therapeutics price target lowered to $5 from $7 at Canaccord
- BioXcel Therapeutics prices 5.6M shares at 48c in public offering
- Bioxcel Therapeutics Restructures Credit and Strengthens Leadership